Q&A Document on the QP Declaration revised
Recommendation
19-21 May 2026
Barcelona, Spain
Leadership with Impact”
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The CMDh* has revised and published its Q&A document on the QP Declaration.
Mainly adjustments were made due to the new Veterinary Medicinal Products Regulation (EU) 2019/6. Also, in several answers a differentiation was made between human and veterinary medicinal products.
Adjustments were also made to question 3 "When the only change in an updated CEP is the name of the HOLDER (the manufacturing site remains the same) what is the rationale for requiring a new QP Declaration?". The additions here can be found in the change mode of the document.
* Co-ordination group for Mutual recognition and Decentralised procedures - human (CMDh)
Related GMP News
15.04.2026ICH Q9 Training Package updated
01.04.2026New EMA GMP Guidelines in the next three Years
01.04.2026New EMA Guidance: Risk Management for Elemental Impurities in Veterinary Medicinal Products
18.03.2026Sampling in the Focus of the FDA
11.03.2026EU Pharma Package: Final Texts officially published
11.03.2026FDA Guidance Plans for 2026